Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
This finding is of particular interest, as genomic and proteomic differences in GPx3 have recently been identified in large cohorts of individuals affected with a similar motor neuron disease, ALS 20,21
Furthermore, as mentioned (Gwyer et al., 2019), BPC 157 inhibits the growth of several tumor lines and can counteract tumor cachexia (Kang et al., 2018), a point combined, as mentioned, with counteracted pro-inflammatory and pro-cachectic cytokines such as IL-6, TNF-, cancer cachexiarelated pathways expression (i.e., FoxO3a, p-AKT, p-mTOR, and P-GSK-3) (Kang et al., 2018)
90-Day On / 30-Day Off This is perhaps the most widely reported cycling pattern: Use Dihexa daily for approximately 90 days (13 weeks) Discontinue completely for 30 days (4 weeks) Repeat the cycle Rationale: Allows receptor sensitivity to reset and minimizes tolerance No scientific evidence supports this particular cycle length 5-Days-On / 2-Days-Off A shorter cycle pattern used by some: Take Dihexa for 5 consecutive days, then skip 2 days Repeat weekly Provides more frequent breaks without long discontinuation Anecdotally reported to maintain responsiveness Continuous Use Some community members report continuous daily use without cycling: Effects may be maintained or may plateau Risk of tolerance development is unknown Long-term safety of continuous use is not established Important Note on Cycling The concept of receptor tolerance and its mitigation through cycling is theoretically grounded in neuropharmacology
This method deposits the active tripeptide into cells where standard oral powders fail
Designed as a strip-based format for researchers evaluating oral mucosal delivery characteristics and formulation behavior
FDA approval to me doesnt mean what it does to some people right, wrong or indifferent, said Cyphert
